Homology Medicines Inc. Launches as a Newly-Formed Genetic Medicines Company Founded Upon a Unique City of Hope Gene Editing and Gene Transfer Platform Technology City of Hope announced that it has licensed its pioneering AAV-based gene editing technology exclusively to Homology Medicines Inc. A City of Hope lab led by Saswati Chatterjee, Ph.D., developed the single platform technology that enables both gene editing and gene therapy with a built-in in vivo delivery system. [City of Hope (Business Wire)] Press Release Regenerating Blood Vessels Gets $2.7 Million Grant Biomedical engineers at The University of Texas at Austin have received a three-year, $2.7 million grant from the U.S. Department of Defense to advance a promising treatment that could help millions of people with diabetes affected by peripheral ischemia, a condition that restricts blood flow to muscles in the lower limbs. [The University of Texas at Austin] Press Release Queen’s Researchers in €2.25m International Project to Tackle Diabetes-Related Blindness The new €2.25m US-Ireland R&D partnership is bringing together a unique team of scientists and clinicians to develop a gene therapy approach with the aim of potentially reversing diabetes-linked blood vessel damage to the retina – the light-sensitive tissue at the back of the eye. Ultimately, the team hopes to prevent disease progression and restore visual function. [Queen’s University Belfast] Press Release TRACT Therapeutics, Inc. Received FDA Approval for a Phase II Trial Using a Patient’s Immune Cells to Prevent Organ Rejection TRACT Therapeutics, Inc. announced that it received Food and Drug Administration (FDA) approval to initiate a Phase II clinical trial to investigate the efficacy and safety of its novel therapy for kidney transplant recipients. [TRACT Therapeutics, Inc. (Business Wire)] Press Release Regenerating Brain Tissue Brings Hope for a New Treatment against Alzheimer’s and Parkinson’s Mexican researchers developed a nanogel that enables the growth of new neurons. Working with animal models, Mexican researchers were able to cross the electroencephalic barrier, introduce a nanogel and achieve the growth of neurons within the gel, which shows that it is possible to promote regeneration of brain tissue. [Investigación y Desarrollo (AlphaGalileo)] Press Release First Gene Therapy Successful Against Human Aging The 44 year-old CEO of BioViva USA Inc. Elizabeth Parrish received two of her own company’s experimental gene therapies: one to protect against loss of muscle mass with age, another to battle stem cell depletion responsible for diverse age-related diseases and infirmities. [BioViva USA Inc.] Press Release Dr. Patrick Soon-Shiong Honored at the Vatican with the 2016 Pontifical Key Visionary Award Dr. Patrick Soon-Shiong, who grew up in Apartheid South Africa and has dedicated his life to pioneering novel cellular therapies for diabetes and cancer, including the development of the revolutionary cancer drug Abraxane, was honored at the Vatican with the 2016 Pontifical Key Visionary Award. [Business Wire] Press Release University of Wisconsin and Harvard Scientists Receive Awards from ASNTR ASNTR awarded The 2016 Bernard Sanberg Memorial Award for Brain Repair to Marina E. Emborg, MD, PhD, an associate professor of medical physics at the University of Wisconsin-Madison. ASNTR also presented The Molly and Bernard Sanberg Memorial Award to Eng H. Lo, PhD, professor of neurology and radiology at Harvard University and Massachusetts General Hospital. [University of South Florida (EurkeAlet!)] Press Release |